|
gptkb:small_cell_lung_carcinoma
|
2-4 months untreated
|
|
gptkb:oat_cell_carcinoma
|
16-24 months (limited stage)
|
|
gptkb:advanced_renal_cell_carcinoma
|
less than 2 years (untreated)
|
|
gptkb:unresectable_malignant_pleural_mesothelioma
|
less than 1 year
|
|
gptkb:Large_cell_lung_cancer
|
8-12 months (advanced stage)
|
|
gptkb:North_American_ALS_patients
|
2 to 5 years after diagnosis
|
|
gptkb:Combined_Small_Cell_Lung_Cancer
|
Less than 1 year (advanced stage)
|
|
gptkb:Anaplastic_thyroid_cancer
|
<6 months
|
|
gptkb:glioblastoma_multiforme
|
12-15 months
|
|
gptkb:small_cell_lung_carcinoma
|
6-12 months with treatment
|
|
gptkb:glioblastoma
|
12-15 months
|
|
gptkb:High-grade_glioma
|
12-18 months (glioblastoma)
|
|
gptkb:Malignant_glioma
|
12-18 months
|
|
gptkb:oat_cell_carcinoma
|
8-13 months (extensive stage)
|
|
gptkb:anaplastic_thyroid_cancer
|
<6 months
|
|
gptkb:anaplastic_thyroid_carcinoma
|
less than 6 months
|
|
gptkb:angioimmunoblastic_T-cell_lymphoma
|
2-3 years
|
|
gptkb:mast_cell_leukemia
|
less than 1 year
|
|
gptkb:locally_advanced_or_metastatic_urothelial_carcinoma
|
12-15 months
|
|
gptkb:non-small_cell_lung_carcinoma
|
less than 1 year (advanced stage)
|